Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

420
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
420
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

955
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
955
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

548
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
548
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

2.4K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Projected hospitalization cost impact of the selective cytopheretic device in pediatric acute kidney injury.

Journal of medical economics·2025
Same author

Selective Cytopheretic Device (QUELimmune): A Leukocyte Processing, Immunomodulatory Device.

Journal of the American Society of Nephrology : JASN·2024
Same author

Blood Volume Analysis and Cardiorenal Syndrome: From Bench to Bedside.

Cardiorenal medicine·2024
Same author

Leukocyte filtration and leukocyte modulation therapy during extracorporeal cardiopulmonary resuscitation in a porcine model of prolonged cardiac arrest.

Scientific reports·2024
Same author

Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states.

Scientific reports·2024
Same journal

Activating transcription factor 3 aggravates renal fibrosis by regulating EGR2-mediated autophagy.

Translational research : the journal of laboratory and clinical medicine·2026
Same journal

Extracellular Vesicles in the Tumor Microenvironment: Diverse Origins, Multifaceted Functions, and Emerging Therapeutic Opportunities.

Translational research : the journal of laboratory and clinical medicine·2026
Same journal

Circ_QRICH1 promotes osteoarthritis progression by sponging miR-214-3p to impact ATF3-mediated chondrocyte ferroptosis.

Translational research : the journal of laboratory and clinical medicine·2026
Same journal

Letter to the Editor: Reflections on "Auricular Vagus Nerve Stimulation Alleviates Cardiac Dysfunction in Takotsubo Syndrome".

Translational research : the journal of laboratory and clinical medicine·2026
Same journal

SynNotch-iNOS CAR-Macrophages Remodel the Tumor Immune Microenvironment and Exhibit Antitumor Efficacy via a CD4<sup>+</sup> T Cell-Dependent Mechanism.

Translational research : the journal of laboratory and clinical medicine·2026
Same journal

Ion channel dysfunction in acute pancreatitis: mechanisms, heterogeneity, and therapeutic prospects.

Translational research : the journal of laboratory and clinical medicine·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

6.9K

The bioartificial kidney.

Deborah A Buffington1, Angela J Westover1, Kimberly A Johnston1

  • 1Innovative Biotherapies, Ann Arbor, Mich.

Translational Research : the Journal of Laboratory and Clinical Medicine
|November 26, 2013
PubMed
Summary
This summary is machine-generated.

Bioengineered kidneys using primary human renal epithelial cells (RECs) offer a more complete renal replacement therapy (RRT). This approach demonstrates metabolic and endocrine functions, improving survival in acute kidney injury and altering inflammatory states.

More Related Videos

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
10:23

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Published on: November 4, 2022

3.0K
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

15.5K

Related Experiment Videos

Last Updated: May 5, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

6.9K
Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
10:23

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Published on: November 4, 2022

3.0K
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

15.5K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Nephrology

Background:

  • Current renal replacement therapies (RRTs) primarily restore kidney filtration, neglecting essential transport, metabolic, and endocrine functions.
  • High mortality rates persist in renal failure despite advancements in dialysis technology.
  • Restoring comprehensive kidney functions is crucial for improving RRT efficacy.

Purpose of the Study:

  • To isolate and expand primary human renal epithelial cells (RECs) for bioengineered applications.
  • To evaluate the differentiated absorptive, metabolic, and endocrine functions of RECs.
  • To assess the efficacy of REC-based bioartificial kidneys in preclinical and clinical settings.

Main Methods:

  • Isolation and expansion of primary human renal epithelial cells (RECs).
  • In vitro and preclinical ex vivo animal studies to assess REC functions.
  • Incorporation of RECs into bioengineered systems (bioartificial kidneys) for RRT.
  • Clinical studies evaluating bioartificial kidneys in patients with acute kidney injury and multiorgan failure.

Main Results:

  • Expanded RECs demonstrated differentiated absorptive, metabolic, and endocrine functions.
  • Bioartificial kidneys incorporating RECs provided effective RRT in preclinical and clinical studies.
  • REC therapy showed systemic metabolic effects, improved survival in acute kidney injury, and modulated leukocyte activation and inflammatory cytokines.

Conclusions:

  • Engineered bioartificial kidneys using RECs offer a transformative approach to RRT.
  • REC therapy demonstrates potential to improve patient survival and reduce morbidity by addressing both renal and inflammatory disease states.
  • This technology represents a groundbreaking platform for advancing lifesaving therapies in renal and inflammatory conditions.